Current through September 17, 2024
The Department imposes the following quantity limitations on
certain drugs.
013.01
QUANTITIES NOT ALLOWED. Payment from Nebraska Medicaid
will not be approved for:
(A) More than a
three month supply of any maintenance medication:
(B) More than a one month supply of any
controlled substance: and
(C) More
than a one month supply of any injectable medication except insulin and those
injectable drugs with a duration of greater than one month from one
dose.
013.02
QUANTITIES. The following types of limits may be
utilized to ensure appropriate utilization and billing:
(A) Maximum quantity over time;
(B) Maximum daily dose;
(C) Maximum days' supply per fill;
(D) Maximum Quantity per fill;
(E) Minimum quantity per fill:
(F) Maximum cost per fill;
(G) Tablet splitting; and
(H) Number of units to require medication be
submitted in multiples of the package size.
013.03
INJECTIONS.
The Department applies the following limitations to injectable drug products:
(A) Only those injections which are either
self-administered by the client or are administered for the client at the
client's place of residence are reimbursable. Injections administered by the
provider or hospital are not reimbursable through the pharmacy services
program:
(B) Whenever available and
necessity warrants, multi-dose vials of medication are dispensed rather than
single-dose vials or unit-dose syringes;
(C) Single-dose syringes may be reimbursed at
the proportionate cost of a multi-dose vial;
(D) Maintenance injectable medications which
are not reconstituted or admixed by the pharmacy prior to administration to the
patient are dispensed and billed for the full month's supply;
(E) Non-maintenance injectable medications
and those injectable medications which must be reconstituted or admixed by the
pharmacy prior to administration to the patient including subcutaneous,
intramuscular, and intravenous medication delivery by large volume parenteral,
piggyback, syringe pump, or other methods may be provided at the pharmacist's
discretion. Courses of therapy of ten days or less duration are billed at the
end of the course of therapy. Courses of therapy of greater than ten days
duration are billed at the end of the course of therapy or after each ten days
of therapy;
(F) Injectable
medications administered by implanted or similar devices may not be billed to
the pharmacy services program when the device is filled in the clinic or
hospital: and
(G) Total parenteral
nutrition is billed through the Durable Medical Equipment and Medical Supplies
program. This includes the amino acids, carbohydrates, lipids and all
additives. All total parenteral nutrition-compatible additives are billed
through the supplier program regardless of who completes the addition of the
ingredient or the method of administration.
013.04
MAINTENANCE
DRUGS. The Department requires any other maintenance drug or any
drug used in a chronic manner be prescribed and dispensed in a minimum of a
one-month supply. Providers will not reduce prescriptions which are written for
quantities larger than a month's supply to a month's supply. The Department
considers prescription splitting to be fraudulent except when such reduction is
done to comply with State or Federal regulations or statute.
013.05
EXCEPTIONS TO QUANTITY
LIMITATIONS. The Department allows the following exceptions to the
quantity limitations of this subsection only for those clients receiving
medications through a non-unit-dose system, except where noted otherwise:
(A) When the prescriber first introduces a
maintenance drug to a patient's course of therapy, the prescriber may prescribe
a smaller Quantity as his or her judgment dictates. Pharmacists must indicate
this is the initial filling of the medication when filing the drug claim. Any
subsequent dispensing of this maintenance drug must be prescribed and dispensed
in at least a month's supply;
(B)
When the prescriber's professional judgment indicates these Quantities of
medication are not in the patient's best medical interest, the prescriber may
prescribe as his or her judgment directs. This includes limitations for lock-in
clients. The pharmacist must maintain documentation when an exception is being
made to the Department's requirements;
(C) The Department will consider replacement
of any lost, misplaced, or stolen drug products for clients only when the
pharmacy provider or prescriber documents the conditions requiring replacement.
The Department will require additional information prior to replacing
controlled substances;
(D) Schedule
II drugs are an exception to the quantity limitations. This also applies to
unit dose systems, unless the Schedule II drug is used in a chronic or
maintenance manner; and
(E) The
Department will accept certain original shelf package sizes of medication,
under the following conditions;
(i) An
original shelf package of 480 ml or less when not packaged in the pint size, is
sufficient for the quantity limitations requirement for liquids. This also
applies to unit dose systems;
(ii)
An original shelf package of 100 tablets or capsules, or less when not
available in the 100 tablet or capsule size, for seldom-prescribed solid dosage
drugs is sufficient for the quantity limitations requirement;
(iii) Original shelf packages of 100 tablets
or capsules of routinely prescribed drugs are not acceptable as sufficient for
fulfillment of the quantity limitations requirement. The full month's supply
must be prescribed and dispensed; and
(iv) Ready-made ointments and creams, when
used in a chronic or maintenance manner, may be dispensed in an original shelf
package size provided the original size is closest to the needed amount of
medication. This also applies to unit dose systems.